Zobrazeno 1 - 10
of 23
pro vyhledávání: '"J E, Axelson"'
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 282(2)
Previous estimates of maternal and fetal placental and nonplacental clearances in pregnant sheep using a two-compartment open model have revealed higher values of fetal placental clearance (CLfm) compared to the maternal placental clearance (CLmf) fo
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 24(3)
In this study, two factors that could affect fetal drug exposure were examined: 1) the extent of elimination of drug delivered to the fetal liver from the placenta via the umbilical vein; and 2) the degree to which there is preferential distribution
Publikováno v:
NIDA research monograph. 154
The development of more sensitive and selective analytical techniques has greatly improved scientists' ability to study the PK, PD, and metabolism of drugs in pregnancy. This chapter has chronicled the evolution of the study of drug disposition in pr
Autor:
K, Yeleswaram, D W, Rurak, E, Kwan, C, Hall, A, Doroudian, M R, Wright, F S, Abbott, J E, Axelson
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 267(1)
Labetalol has been previously shown to cause significant maternal and fetal metabolic effects in pregnant sheep after maternal administration. To investigate these observations further, the present study describes the pharmacokinetics, metabolism and
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 21(2)
Labetalol causes significant maternal and fetal metabolic effects in pregnant sheep (Yeleswaram et al., J. Pharmacol. Exp. Ther. 262, 683-691 (1992)). This study was undertaken to investigate the contribution of skeletal muscles in the development of
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 262(2)
The maternal-fetal disposition of labetalol, a combined alpha-1 and beta adrenergic blocker, and its pharmacodynamics in pregnancy are not well understood. This study describes the pharmacokinetics, cardiovascular and metabolic effects of labetalol i
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 262(1)
Ritodrine infusion to fetal lambs causes numerous metabolic perturbations including hypoxemia. To investigate these changes further and to elucidate a mechanism for the development of hypoxemia, ritodrine was infused at rate of 2.6 micrograms/min int
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 258(3)
The disposition of the beta-2 adrenoreceptor agonist, ritodrine, has been examined in the fetal lamb during and after constant rate fetal intravenous infusion (8-24 h). Samples were collected from the fetal femoral artery, umbilical vein, maternal fe
Publikováno v:
Journal of developmental physiology. 15(1)
Surveys of drug use in pregnancy demonstrate that a significant proportion of human fetuses are exposed to prescription and non-prescription drugs antenatally or during labor, although recently a decrease in licit drug consumption during pregnancy ma
Publikováno v:
Research communications in chemical pathology and pharmacology. 67(3)
Quantitation of tocainide carbamoyl-O-B-D-glucuronide, a major metabolite of the antiarrhythmic agent, tocainide, was previously reported using sodium hydroxide hydrolysis (pH greater than 12) of the glucuronide followed by gas chromatographic analys